Cigna Group

CI Healthcare Healthcare Plans

Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 6.68%, EPS grew 10.2%, free cash flow grew 66.9% and total debt rose 3.61%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

282.53 0.81 −0.29%
Market cap
$74.7B
P/E
11.7×
Fwd P/E
11.4×
Dividend yield
2.19%
F-score
8/9
Altman Z
2.62
Beneish M
−2.47
Dividend safety
82/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
18.85 23.20 17.75 15.23 9.01 14.59 15.04 17.83 22.56 12.41
Piotroski F-Score
7 7 6 7 8 6 9 5 7 8
Altman Z-Score
1.21 1.50 0.70 1.66 1.83 1.93 2.33 2.21 2.43 2.62
P/S ratio
0.87 1.22 0.96 0.50 0.47 0.45 0.55 0.47 0.31 0.27
P/FCF ratio
9.72 14.06 14.45 9.11 8.21 12.86 13.52 8.90 8.64 8.75
Altman Z″-Score (non-manufacturers)
(0.80) (0.52) 0.37 0.66 1.10 0.98 1.15 1.02 0.88 1.10
Beneish M-Score
(2.73) (2.64) (1.70) (1.50) (2.45) (2.40) (2.48) (2.69) (2.47) (2.47)
P/Operating CF
40.92 88.38 371.78 27.52 17.69 18.15 47.41 62.12 14.85 11.94
Dividend Safety Score
— — — — — — — — — 82
P/B ratio
2.52 3.71 1.14 1.70 1.51 1.65 2.23 1.97 1.88 1.75
Price to Tangible BV
4.47 7.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
0.92 1.27 1.76 0.71 0.62 0.61 0.69 0.59 0.41 0.35
EV/EBITDA
9.87 11.82 17.60 9.35 9.01 9.78 10.95 9.87 8.35 8.12
EV/Operating CF
9.07 13.04 22.67 11.56 9.54 14.77 14.40 9.67 9.83 10.12
EV/FCF
10.24 14.74 26.36 13.00 10.67 17.59 16.94 11.16 11.37 11.59
Quick Ratio
0.39 0.38 0.62 0.61 0.77 0.68 0.69 0.65 0.65 0.72
Current Ratio
0.39 0.38 0.62 0.61 0.77 0.68 0.69 0.65 0.65 0.72
Net Debt/EBITDA
0.50 0.55 7.96 2.80 2.08 2.63 2.21 2.00 2.00 1.99
Debt/Assets
8.48% 8.81% 27.72% 24.01% 21.18% 21.74% 21.61% 20.25% 20.51% 19.92%
Debt/Equity
0.37 0.40 1.04 0.83 0.65 0.71 0.70 0.67 0.78 0.75
Asset Turnover
0.68 0.69 0.45 0.99 1.03 1.12 1.21 1.32 1.60 1.75
Operating CF/Net income
2.16 1.83 1.43 1.86 1.22 1.34 1.29 2.29 3.02 1.61
Capex/Depreciation
(0.76) (0.83) (0.76) (0.29) (0.39) (0.39) (0.44) (0.52) (0.51) (0.44)
Interest Coverage
11.11 15.64 8.35 4.80 5.67 6.57 6.88 5.90 6.56 6.53
ROE
14.49% 16.31% 9.63% 11.82% 17.68% 11.02% 14.60% 11.36% 7.85% 14.33%
ROA
3.21% 3.69% 2.45% 3.30% 5.44% 3.46% 4.49% 3.48% 2.23% 3.80%
ROIC
12.39% 15.23% 3.26% 6.46% 6.97% 6.55% 7.56% 7.69% 8.96% 8.76%
Return on Tangible Assets
(10.04%) (12.37%) (35.17%) (60.23%) (199.29%) (64.43%) (75.39%) (41.19%) (21.79%) (49.05%)
Average Days of Receivables
87.54 77.86 119.89 37.59 39.57 42.02 45.77 42.16 42.25 43.64
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
24.57% 23.99% 24.53% 9.15% 8.77% 7.48% 7.30% 7.59% 6.01% 5.32%
Intangible Assets out of Total Assets
0.10 0.11 0.55 0.52 0.51 0.52 0.54 0.49 0.47 0.47
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Graham Net Nets
(0.95) (0.71) (1.97) (1.17) (1.02) (1.06) (0.71) (0.84) (1.01) (1.03)
Graham Number
93.32 103.61 200.13 190.92 267.77 222.23 263.53 248.13 201.30 279.90
Earnings Yield
5.31% 4.31% 5.63% 6.57% 11.10% 6.85% 6.65% 5.61% 4.43% 8.06%
Free Cash Flow Yield
10.29% 7.11% 6.92% 10.97% 12.18% 7.78% 7.40% 11.24% 11.57% 11.43%
Revenue per Share
156.01 166.63 197.24 408.51 439.48 515.05 583.17 664.41 881.65 1,030.58
Operating CF per Share
15.77 16.29 15.28 25.23 28.36 21.28 27.96 40.20 36.97 35.99
Capex per Share
(1.81) (1.88) (2.14) (2.79) (3.00) (3.41) (4.18) (5.35) (5.02) (4.54)
Free Cash Flow per Share
13.96 14.41 13.14 22.44 25.36 17.86 23.78 34.84 31.96 31.45
Cash per Share
12.47 11.85 15.63 12.29 27.90 15.03 19.14 26.62 26.94 28.78
Shareholders Equity per Share
53.76 54.65 166.37 120.62 137.89 139.45 144.37 157.35 147.14 156.98
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
53.76 54.65 166.37 120.62 137.89 139.45 144.37 157.35 147.14 156.98
Free Cash Flow
3,565.00 3,615.00 3,242.00 8,435.00 9,256.00 6,037.00 7,361.00 10,240.00 8,957.00 8,389.00
Working Capital
(20,139.00) (19,649.00) (12,060.00) (12,891.00) (8,449.00) (12,027.00) (12,667.00) (16,233.00) (19,414.00) (15,795.00)
Capital Expenditures
(461.00) (471.00) (528.00) (1,050.00) (1,094.00) (1,154.00) (1,295.00) (1,573.00) (1,406.00) (1,212.00)
Net Current Asset Value
(32,893.00) (36,158.00) (92,356.00) (89,995.00) (77,550.00) (82,637.00) (70,639.00) (76,138.00) (78,483.00) (75,498.00)
EV/EBIT
11.82 13.52 20.55 13.58 12.11 13.37 14.76 13.38 10.81 10.57
Capex to Sales
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00
Price to Operating Income
11.22 12.89 11.26 9.52 9.32 9.77 11.78 10.68 8.22 7.98
Other line items
Depreciation/Fixed assets
0.40 0.36 0.15 0.83 0.67 0.79 0.78 0.82 0.76 0.76
Cash ROIC
16.25% 16.34% 3.71% 9.65% 9.91% 7.03% 9.01% 12.05% 11.09% 10.36%
Accounts Receivable Turnover
3.97 4.53 3.91 9.66 9.66 9.30 8.46 8.64 9.66 8.94
Accounts Payable Turnover
1.02 1.12 1.53 2.01 1.90 1.65 1.38 1.36 1.17 0.87
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
362.06 303.68 199.79 184.09 210.06 238.85 281.77 285.35 356.60 435.59
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
10,031.00 9,236.50 12,449.00 15,898.00 16,603.50 18,716.00 21,337.50 22,595.50 25,581.00 30,738.00
Average Payables
23,837.50 22,582.00 18,043.50 15,306.00 17,184.50 20,394.50 23,404.50 26,606.50 33,063.50 39,375.50
Average Assets
58,224.00 60,559.50 107,492.50 154,500.00 155,612.50 155,170.00 149,387.00 148,323.00 154,321.00 156,900.00
Average Common Equity
12,885.50 13,719.00 27,373.00 43,189.50 47,836.00 48,729.00 45,909.00 45,466.00 43,743.50 41,558.50

Fold the line items

Columns are period end dates